Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Asian Pac J Cancer Prev ; 16(8): 3319-23, 2015.
Article in English | MEDLINE | ID: mdl-25921138

ABSTRACT

BACKGROUND: Community pharmacists play an important role in tobacco control and adequate training on smoking cessation is essential. MATERIALS AND METHODS: A quasi-experimental pre-test/post-test design was used. A one-day workshop on smoking cessation organized by Indonesian Pharmacists Association as part of PCE program was offered to 133 community pharmacists. The workshop consisted of a 3-hour lecture and a 3-hour role-play session. Pre-training and post-training surveys assessed the impact of training on parameters including knowledge, perceived role and self-efficacy with respect to smoking cessation counseling practices. Intention and ability to perform counseling using the 5A framework was assessed after training only. RESULTS: After PCE, knowledge score significantly increased from 24.9±2.58 to 35.7±3.54 (p<0.001). Perceived role and self-efficacy in smoking cessation counseling also significantly increased from 25.8±2.73 to 28.7±2.24, and 27.6±4.44 to 32.6±3.63, respectively (p<0.001). After the workshop, most participants were willing to ask, advise, and assess patients who ready to quit, but were still less likely to assist in quitting plans and arranging follow up counseling. More than 75% pharmacists were able to perform cessation counseling and 65% of them can completely perform a 5A brief intervention. CONCLUSIONS: PCE can enhance pharmacists' knowledge, perceived role, self-efficacy in cessation counseling practices, and create willingness and ability to perform cessation counseling. Future training is recommended to improve skills in assisting quitting plans and arranging follow up.


Subject(s)
Community Pharmacy Services , Counseling/education , Education, Pharmacy, Continuing/methods , Pharmacists , Professional Role , Self Efficacy , Smoking Cessation , Smoking/therapy , Adult , Attitude of Health Personnel , Clinical Competence , Female , Humans , Indonesia , Male
2.
Asian Pac J Cancer Prev ; 15(24): 10783-6, 2014.
Article in English | MEDLINE | ID: mdl-25605176

ABSTRACT

BACKGROUND: Smoking remains the major preventable cause of death worldwide, especially cancer-related death. Evidence clearly indicates that tobacco-related morbidity and mortality is reduced by smoking cessation. Pharmacists are well-positioned to provide tobacco cessation services an involvement of pharmacists in smoking cessation is encouraged by several organizations. While Indonesia's prevalence of smoking is in the first rank in Asian countries, none of the pharmacy schools in Indonesia are currently offering tobacco-related courses in their existing curricula at present. Our study aimed to develop and to evaluate the effectiveness of tobacco education (TE) for pharmacy students in Indonesia. MATERIALS AND METHODS: A 6-hour TE was developed and evaluated using pre-test/post-test with control group design. A total of 137 fifth-year pharmacy students at Gadjah Mada University (GMU), Yogyakarta, were chosen as an intervention group while a total of 105 fifth-year students of Islamic University of Indonesia, (UII) served as the control group. Knowledge, perceived-role, self-efficacy, and ability to perform counseling using the 5A's framework were evaluated. RESULTS: A significant improvement (P < 0.001) in knowledge, perceived-role, and self-efficacy was found in the intervention group but not in the control group. In addition, we revealed that 89.7% of the intervention group were able to perform counseling using 5A's. CONCLUSIONS: The developed TE significantly improved student knowledge, perceived-rolse, self-efficacy, and created an ability to perform cessation counseling. Integration of TE education in curricula of Indonesian pharmacy schools nation-wide should be encouraged.


Subject(s)
Patient Education as Topic , Self Efficacy , Smoking Prevention , Students, Pharmacy , Tobacco Use Cessation , Tobacco Use Disorder/therapy , Adult , Case-Control Studies , Counseling , Female , Follow-Up Studies , Humans , Indonesia , Male , Prognosis , Tobacco Use Disorder/diagnosis , Tobacco Use Disorder/psychology
3.
Health Policy Plan ; 27(5): 374-83, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21859775

ABSTRACT

The aim of this study was to analyse the contemporary policies regarding avian and human pandemic influenza control in three South-East Asia countries: Thailand, Indonesia and Vietnam. An analysis of poultry vaccination policy was used to explore the broader policy of influenza A H5N1 control in the region. The policy of antiviral stockpiling with oseltamivir, a scarce regional resource, was used to explore human pandemic influenza preparedness policy. Several policy analysis theories were applied to analyse the debate on the use of vaccination for poultry and stockpiling of antiviral drugs in each country case study. We conducted a comparative analysis across emergent themes. The study found that whilst Indonesia and Vietnam introduced poultry vaccination programmes, Thailand rejected this policy approach. By contrast, all three countries adopted similar strategic policies for antiviral stockpiling in preparation. In relation to highly pathogenic avian influenza, economic imperatives are of critical importance. Whilst Thailand's poultry industry is large and principally an export economy, Vietnam's and Indonesia's are for domestic consumption. The introduction of a poultry vaccination policy in Thailand would have threatened its potential to trade and had a major impact on its economy. Powerful domestic stakeholders in Vietnam and Indonesia, by contrast, were concerned less about international trade and more about maintaining a healthy domestic poultry population. Evidence on vaccination was drawn upon differently depending upon strategic economic positioning either to support or oppose the policy. With influenza A H5N1 endemic in some countries of the region, these policy differences raise questions around regional coherence of policies and the pursuit of an agreed overarching goal, be that eradication or mitigation. Moreover, whilst economic imperatives have been critically important in guiding policy formulation in the agriculture sector, questions arise regarding whether agriculture sectoral policy is coherent with public health sectoral policy across the region.


Subject(s)
Health Policy , Influenza A Virus, H5N1 Subtype , Influenza in Birds/prevention & control , Influenza, Human/prevention & control , Pandemics/prevention & control , Public Health , Animals , Humans , Indonesia/epidemiology , Influenza in Birds/epidemiology , Influenza, Human/epidemiology , Poultry , Poultry Diseases , Poultry Products/economics , Public Health/economics , Retrospective Studies , Thailand/epidemiology , Vietnam/epidemiology
4.
J Med Assoc Thai ; 93(10): 1223-31, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20973328

ABSTRACT

BACKGROUND: The use of statins at Ramathibodi, a teaching hospital, has been rising rapidly OBJECTIVE: Determine how price, volume, and drug mix (use of five brands and one generic) affect expenditure. MATERIAL AND METHOD: Dispensing records of the six statins were retrieved from database and analyzed for factors contributing to increased drug expense. RESULTS: Overall, statins' expenditure rose 35.6% and 6.4% in 2006 and 2007 respectively, mainly from civil servant outpatients who are more likely to be prescribed with brand drugs, even among new patients. In all schemes, volume effect was positive, more people use statins, and each one used a larger quantity of drug in 2007 than in 2005. The price effect was negative. Drug mix effect indicated that there was a shift from higher to lower priced drugs in capitation scheme and from lower to higher priced original drugs in a fee-for-service scheme. CONCLUSION: There is a trend of more statins utilization but with a different pattern of drug prescribed between health schemes and possible drug over-prescribed in some patients. However indication for statin use was not studied, which needs to be considered. With high use of original drugs, effective policy initiative to promote generic drug use should be implemented in order to efficiently use the limited health care resources.


Subject(s)
Drug Costs/trends , Drug Prescriptions/statistics & numerical data , Drug Utilization/statistics & numerical data , Drugs, Generic/therapeutic use , Health Expenditures/trends , Hydroxymethylglutaryl-CoA Reductase Inhibitors/economics , Practice Patterns, Physicians'/statistics & numerical data , Drug Costs/statistics & numerical data , Drug Prescriptions/economics , Drug Utilization/economics , Drug Utilization/trends , Drugs, Generic/economics , Health Expenditures/statistics & numerical data , Hospitals, Teaching , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/supply & distribution , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Insurance, Pharmaceutical Services/economics , Thailand
5.
Pharm. pract. (Granada, Internet) ; 6(3): 113-120, jul.- sept. 2008. tab
Article in En | IBECS | ID: ibc-68551

ABSTRACT

Objective: To suggest revisions to the Thai pharmacy competency standards and determine the perceptions of Thai pharmacy practitioners and faculty about the proposed pharmacy competency standards. Methods: The current competency standards were revised by brainstorming session with nine Thai pharmacy experts according to their perceptions of society’s pharmacy needs. The revised standards were proposed and validated by 574 pharmacy practitioners and faculty members by using a written questionnaire. The respondents were classified based on their practice setting. Results: The revision of pharmacy competency standard proposed the integration and addition to current competencies. Of 830 distributed questionnaires, 574 completed questionnaires were received (69.2% response rate). The proposed new competency standards contained 7 domains and 46 competencies. The majority of the respondents were supportive of all 46 proposed competencies. The highest ranked domain was Domain 1 (Practice Pharmacy within Laws, Professional Standards, and Ethics). The second and third highest expectations of pharmacy graduates were Domain 4 (Provide pharmaceutical care) and Domain 3 (Communicate and disseminate knowledge effectively). Conclusion: The expectation for pharmacy graduates’ competencies were high and respondents encouraged additional growth in multidisciplinary efforts to improve patient care (AU)


Objetivo: Sugerir revisión a los estándares de competencia de farmacia tailandeses y determinar las percepciones de los facultativos farmacéuticos tailandeses sobre los estándares de competencia propuestos. Métodos: Se revisaron los estándares de competencia actuales en una sesión de brainstorming con nueve expertos farmacéuticos tailandeses de acuerdo a sus percepciones de las necesidades de la sociedad sobre los farmacéuticos. Los estándares revisados fueron propuestos y validados por 574 farmacéuticos en ejercicio mediante un cuestionario escrito. Se clasificó a los respondentes según su lugar de ejercicio. Resultados: La revisión de los estándares actuales de competencia propuso la integración y adición de nuevas competencias. De los 830 cuestionarios distribuidos, se recibieron 574 cuestionarios completos (69,2% tasa de respuesta). Los nuevos estándares de competencia propuestos contenían 7 dominios y 46 competencias. La mayoría de los respondentes apoyaron todas las 46 competencias. El dominio más valorado fue el Dominio 1 (Ejercicio de Farmacia en Leyes, Estándares profesionales, y Ética). Los segundo y tercero con más expectativas entre los graduados en farmacia fueron el Dominio 4 (Provisión de atención farmacéutica) y Dominio 3 (Comunicar y diseminar conocimientos efectivamente). Conclusión: Las expectativas de las competencias de los graduados en farmacia fueron altas y los respondentes valoraban un crecimiento adicional de los esfuerzos multidisciplinarios para mejorar la atención al paciente (AU)


Subject(s)
Humans , Professional Competence , Pharmaceutical Services/trends , Pharmacists/statistics & numerical data , Thailand , Education, Pharmacy/trends
6.
Value Health ; 11 Suppl 1: S43-51, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18387067

ABSTRACT

OBJECTIVE: The national essential drug committee in Thailand suggested that only one of thiazolidinediones be included in hospital formulary but little was know about their cost-effectiveness values. This study aims to determine an incremental cost-effectiveness ratio of pioglitazone 45 mg compared with rosiglitazone 8 mg in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand. METHODS: A Markov diabetes model (Center for Outcome Research model) was used in this study. Baseline characteristics of patients were based on Thai diabetes registry project. Costs of diabetes were calculated mainly from Buddhachinaraj hospital. Nonspecific mortality rate and transition probabilities of death from renal replacement therapy were obtained from Thai sources. Clinical effectiveness of thiazolidinediones was retrieved from a meta-analysis. All analyses were based on the government hospital policymaker perspective. Both cost and outcomes were discounted with the rate of 3%. Base-case analyses were analyzed as incremental cost per quality-adjusted life year (QALY) gained. A series of sensitive analyses were performed. RESULTS: In base-case analysis, the pioglitazone group had a better clinical outcomes and higher lifetime costs. The incremental cost per QALY gained was 186,246 baht (US$ 5389). The acceptability curves showed that the probability of pioglitazone being cost-effective was 29% at the willingness to pay of one time of Thai gross domestic product per capita (GDP per capita). The effect of pioglitazone on %HbA1c decrease was the most sensitive to the final outcomes. CONCLUSIONS: Our findings showed that in type 2 diabetic patients who cannot control their blood glucose under the combination of sulfonylurea and metformin, the use of pioglitazone 45 mg fell in the cost-effective range recommended by World Health Organization (one to three times of GDP per capita) on average, compared to rosiglitazone 8 mg. Nevertheless, based on sensitivity analysis, its probability of being cost-effective was quite low. Hospital policymakers may consider our findings as part of information for the decision-making process.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/economics , Hypoglycemic Agents/therapeutic use , Metformin/economics , Metformin/therapeutic use , Sulfonylurea Compounds/economics , Sulfonylurea Compounds/therapeutic use , Thiazolidinediones/economics , Thiazolidinediones/therapeutic use , Cost-Benefit Analysis , Diabetes Complications/epidemiology , Economics, Pharmaceutical , Female , Humans , Incidence , Male , Markov Chains , Middle Aged , Registries , Rosiglitazone , Thailand/epidemiology , Treatment Outcome
7.
Am J Pharm Educ ; 72(1): 09, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-18322571

ABSTRACT

OBJECTIVE: To evaluate the curricula content of Thai pharmacy schools based on the Thai pharmacy competency standards. METHODS: Course syllabi were collected from 11 pharmacy schools. A questionnaire was developed based on the Thai pharmacy competency standards. Course coordinators completed the questionnaire assessing the curricula content. RESULTS: The curricula for both the bachelor of science in pharmacy degree (BS Pharm) and doctor of pharmacy (PharmD) degree programs included the minimum content required by the 8 competency domains. The dominant content area in BS Pharm degree programs was product-oriented material. The content ratio of patient to product to social and administrative pharmacy in the BS Pharm degree programs was 2:3:1, respectively. However, the content ratio suggested by the Thai Pharmacy Council was 3:2:1, respectively. For the PharmD programs, the largest content area was patient-oriented material, which was in agreement with the framework suggested by the Thai Pharmacy Council. CONCLUSIONS: The curricula of all Thai pharmacy schools met the competency standards; however, some patient-oriented material should be expanded and some product-oriented content deleted in order to meet the recommended content ratio.


Subject(s)
Competency-Based Education/standards , Curriculum/standards , Education, Pharmacy/standards , Humans , Professional Competence , Schools, Pharmacy , Students, Pharmacy , Surveys and Questionnaires , Thailand
8.
Pharm Pract (Granada) ; 6(3): 113-20, 2008 Jul.
Article in English | MEDLINE | ID: mdl-25177401

ABSTRACT

OBJECTIVE: To suggest revisions to the Thai pharmacy competency standards and determine the perceptions of Thai pharmacy practitioners and faculty about the proposed pharmacy competency standards. METHODS: The current competency standards were revised by brainstorming session with nine Thai pharmacy experts according to their perceptions of society's pharmacy needs. The revised standards were proposed and validated by 574 pharmacy practitioners and faculty members by using a written questionnaire. The respondents were classified based on their practice setting. RESULTS: The revision of pharmacy competency standard proposed the integration and addition to current competencies. Of 830 distributed questionnaires, 574 completed questionnaires were received (69.2% response rate). The proposed new competency standards contained 7 domains and 46 competencies. The majority of the respondents were supportive of all 46 proposed competencies. The highest ranked domain was Domain 1 (Practice Pharmacy within Laws, Professional Standards, and Ethics). The second and third highest expectations of pharmacy graduates were Domain 4 (Provide pharmaceutical care) and Domain 3 (Communicate and disseminate knowledge effectively). CONCLUSION: The expectation for pharmacy graduates' competencies were high and respondents encouraged additional growth in multidisciplinary efforts to improve patient care.

SELECTION OF CITATIONS
SEARCH DETAIL
...